IQ-AI subsidiary gets second FDA rare paediatric disease designation - Share Prices

Retrieved on: 2024-05-20 22:21:09

Tags for this article:

Food and Drug Administration

Priority review

Atypical teratoid rhabdoid tumor

Artificial intelligence

Alliance News Ltd.

LONDON

Imaging Biometrics LLC

Click the tags to see associated articles and topics

IQ-AI subsidiary gets second FDA rare paediatric disease designation - Share Prices. View article details on hiswai:

Excerpt

The London-based medical services company acquired Imaging Biometrics, a Wisconsin-based healthcare imaging software firm, in 2018. On May 10, the FDA ...

Article found on: shareprices.com

View Original Article